[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617329":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":24,"locations":28,"responsibleParty":48,"collaborators":24,"id":52,"slug":24,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":24,"eligibilityCriteria":57,"healthyVolunteers":53,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":24,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":24,"overallStatus":31,"whyStopped":24,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"University of Sao Paulo","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ayahuasca","EXPERIMENTAL","oral ayahuasca",[13],"Drug: Ayahuasca",{"label":15,"type":16,"description":17,"interventionNames":18},"esketamine","ACTIVE_COMPARATOR","oral esketamine",[19],"Drug: Esketamine",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG",[9],null,{"type":22,"name":26,"description":17,"armGroupLabels":27,"otherNames":24},"Esketamine",[15],[29],{"facility":30,"status":31,"city":32,"state":33,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Hospital das Clínicas da FMRP-USP","RECRUITING","Ribeirão Preto","São Paulo","14049900","Brazil",{"type":37,"coordinates":38},"Point",[39,40],-47.81028,-21.1775,{"lat":40,"lon":39},[43],{"name":44,"role":45,"phone":46,"phoneExt":24,"email":47},"Rafael Guimarães Santos","CONTACT","5516997721969","banisteria@gmail.com",{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Rafael Guimarães dos Santos","PhD","100617329",false,"NCT07317206","Ayahuasca, Esketamine and PTSD","Effects of Single Dose of Ayahuasca or Esketamine on Posttraumatic Stress Disorder: a Randomized, Double-blinded Study","Inclusion Criteria:\n\n* posttraumatic stress disorder\n\nExclusion Criteria:\n\n* psychiatric and other medical comorbidities","ALL","18 Years","65 Years",{"count":62,"type":63},10,"ESTIMATED","INTERVENTIONAL",[66],"PHASE2","Double-blind, randomized trial comparing a single dose of oral ayahuasca or esketamine in patients with posttraumatic stress disorder.",[69],"Posttraumatic Stress Disorder (PTSD)","2025-12-19",{"date":72,"type":73},"2026-01-05","ACTUAL",{"date":75,"type":73},"2025-12-20",{"date":77,"type":63},"2026-07",{"name":5,"class":6},1]